Molecular and clinical genetics of the transcription factor GLIS3 in Chinese congenital hypothyroidism

Rui-Jia Zhang,Jun-Xiu Zhang,Wen-Hua Du,Feng Sun,Ya Fang,Cao-Xu Zhang,Zheng Wang,Feng-Yao Wu,Bing Han,Wei Liu,Shuang-Xia Zhao,Jun Liang,Huai-Dong Song
DOI: https://doi.org/10.1016/j.mce.2021.111223
IF: 4.369
2021-05-01
Molecular and Cellular Endocrinology
Abstract:<p>The transcription factor GLIS3 is an important factor in hormone biosynthesis and thyroid development, and mutations in <em>GLIS3</em> are relatively rare. Deletions of more than one of the 11 exons of <em>GLIS3</em> occur in most patients with various extrathyroidal abnormalities and congenital hypothyroidism (CH), and only 18 missense variants of <em>GLIS3</em> related to thyroid disease have been reported. The aim of this study was to report the family history and molecular basis of patients with CH who carry <em>GLIS3</em> variants. Three hundred and fifty-three non-consanguineous infants with CH were recruited and subjected to targeted exome sequencing of CH-related genes. The transcriptional activity and cellular localization of the variants in <em>GLIS3</em> were investigated <em>in vitro</em>. We identified 20 heterozygous <em>GLIS3</em> exonic missense variants, including eight novel sites, in 19 patients with CH. One patient carried compound heterozygous <em>GLIS3</em> variants (p.His34Arg and p.Pro835Leu). None of the variants affected the nuclear localization. However, three variants (p.His34Arg, p.Pro835Leu, and p.Ser893Phe) located in the N-terminal and C-terminal regions of the GLIS3 protein downregulated the transcriptional activation of several genes required for thyroid hormone (TH) biosynthesis. This study of patients with CH extends the current knowledge surrounding the spectrum of <em>GLIS3</em> variants and the mechanisms by which they cause <strong>TH</strong> biosynthesis defects.</p>
cell biology,endocrinology & metabolism
What problem does this paper attempt to address?